[Latest] Global Ultrasonic Dissection Devices Market Size/Share Worth USD 25 Billion by 2030 at a 11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 24, 2023 13:30 ET
|
Custom Market Insights
Austin, TX, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Ultrasonic Dissection Devices Market Size, Trends and Insights By Product...
Global Laparoscopic Devices Market Size To Grow USD 16.3 Billion By 2032 | CAGR of 8.5%
May 29, 2023 12:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 29, 2023 (GLOBE NEWSWIRE) -- The Global Laparoscopic Devices Market Size is to grow from USD 7.2 billion in 2022 to USD 16.3 billion by 2032, at a Compound Annual...
Suture Ease Showcases Two New Product Offerings at SAGES 2022
March 15, 2022 12:00 ET
|
Suture Ease
SAN JOSE, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Suture Ease, a leading developer of medical devices that close fascial defects after laparoscopic surgery, will exhibit at the annual Society of...
Reprocessed Medical Devices Market ($4.5Bn by 2028) Growth Forecast at 14.5% CAGR During 2022 to 2028 COVID Impact and Global Analysis by Vantage Market Research
March 01, 2022 02:40 ET
|
Vantage Market Research
WASHINGTON, March 01, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Reprocessed Medical Devices Market finds that increasing the adoption of Reprocessed Medical...
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel
July 25, 2017 07:55 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Jul 25, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
June 06, 2017 12:25 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Jun 6, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics to Provide Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
May 22, 2017 07:57 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - May 22, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be...
Arch Therapeutics to Provide Corporate Update at the 29th Annual Roth Conference on Monday, March 13, 2017
March 06, 2017 07:57 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Mar 6, 2017) - Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and...
Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference
February 27, 2017 08:18 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Feb 27, 2017) - Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic...
Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering
February 21, 2017 09:08 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Feb 21, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a developer of innovative materials as hemostatic and wound care devices, today...